Proton Therapy Systems Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global proton therapy systems market is segmented By Type(Rotating Proton Therapy Systems, Non-Rotating Proton Therapy Systems), By Set-Up(Multi-Room Systems, Compact/ Single-Room Systems), By Application(Prostate Cancer, Breast Cancer, Eye Melanoma, Esophageal Cancer, Liver Cancer, Lung Cancer, Others) By End-User(Hospitals, Academic and Research Institutes, Cancer Centers and Others)

Market Overview

Global proton therapy systems market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2024-2031.

Proton therapy is a type of radiation therapy. It is a treatment that uses high-powered energy to treat cancer and some noncancerous tumors. Radiation therapy using X-rays has long been used to treat these conditions. Proton therapy is a newer type of radiation therapy that uses energy from positively charged particles (protons). It painlessly delivers radiation to treat some types of cancer. At high energy, protons can destroy cancer cells.

Proton therapy is most widely used in the treatment of various types of cancers such as head and neck cancers, prostate cancer, breast cancer, lung cancer, liver cancer and other types of cancers as well as some non-cancerous tumors in children and adults. The therapy works by disrupting the tumor’s DNA and destroying tumor cells. Protons are separated from hydrogen atoms and spread up in a particle accelerator such as a synchrotron or cyclotron. The energy within the proton beam can be adjusted based on the depth of the tumor so that different amounts of radiation can be delivered to different parts of the tumor.

Market Scope

Market Dynamics: Drivers

Increasing adoption in cancer treatment 

The increasing adoption of proton therapy systems in various types of cancers is expected to drive the market over the forecast period. Proton therapy offers superior dose distribution and precision compared to conventional radiation therapy, making it particularly advantageous for treating various types of cancers located near critical organs and in pediatric patients. 

For instance, on October 23, 2022, Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, released that it is developing the MEVION S250-FIT Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

In addition, proton therapy has the potential to reduce the risk of long-term side effects and secondary cancers because it allows for better sparing of healthy tissues surrounding the tumor. This can lead to improved patient outcomes and quality of life. 

For instance, on July 24, 2023, a private hospital opened Hong Kong’s first proton therapy center, offering cancer patients an alternative treatment promising higher precision and fewer side effects. It has two proton therapy machines, the proton therapy system includes a four-metre-wide synchrotron energy accelerator, a beam transport system that goes across two levels and two gantries held by two radiation-shielded bunker chambers.

Moreover, ongoing research and development in the field of proton therapy are likely to lead to further innovations and improvements, potentially expanding its applications to a wider range of cancer types. This could drive interest in adopting proton therapy systems.

Further, the increasing prevalence of cancer, advancements and innovations in the proton therapy systems, rising FDA approvals, increasing clinical trials, increasing awareness and technological advancements are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications associated with the equipment, side effects associated with proton therapy and the high cost of the equipment, which leads to unaffordable to many patients are expected to hamper the market. 

Segmentation Analysis

The global proton therapy systems market is segmented based on type, set-up, application and region.

The rotating proton therapy systems segment accounted for approximately 39.9% of the proton therapy systems market share

The rotating proton therapy systems segment is expected to hold the largest market share over the forecast period. In proton therapy systems, a special device known as a gantry can rotate 360 degrees by using a large magnet to focus the stream of protons into a thin beam, just 5 millimeters wide. The magnet then guides the beam and directs it at the tumor from multiple angles, as the gantry rotates around the patient. The energy within the proton beam can be adjusted based on the depth of the tumor so that different amounts of radiation can be delivered to different parts of the tumor.

For instance, on February 4, 2021, Varian started the installation of the cyclotron and gantry for its ProBeam 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger Cancer Institute. The cyclotron and gantry are core pieces of equipment of the ProBeam 360° system.

Moreover, rotating proton therapy systems are designed to precisely target cancerous tumors while minimizing damage to surrounding healthy tissues. Protons have a property called the Bragg peak, which allows them to deposit most of their energy at a specific depth within the body. By rotating the proton beam around the patient from multiple angles, the system can deliver radiation precisely to the tumor from various directions, ensuring maximum tumor coverage while minimizing exposure to critical structures.

Geographical Analysis

North America accounted for approximately 39.1% of the market share 

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption. North America especially the United States is known for its strong presence of major players such as pharmaceutical companies and medical device companies including proton therapy companies. The presence of major players actively performing in clinical trials, leads to the development of innovations in the proton therapy systems.

Furthermore, the increasing number of cancer cases in the region leads to the increasing adoption of proton therapy systems in the region. For instance, according to the American Cancer Society, Inc., in 2022, there is an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. This increasing incidence is expected to increase the adoption of proton therapy systems for better treatment.

In addition, on April 03, 2023, P-Cure released the clearance of its Adaptive Proton Therapy Solution by the FDA for sale in the USA. P-Cure, a high-med-tech company, has developed affordable proton therapy technology for targeted treatment of cancer with significantly reduced treatment-related side effects.

Competitive Landscape

The major global players in the proton therapy systems market include Varian Medical Systems, Inc., Sumitomo Heavy Industries, Ltd., Mevion Medical Systems, Provision Healthcare, Optivus Proton Therapy, Inc., Hitachi, Ltd., MITSUBISHI ELECTRIC CORPORATION and among others. 

Key Developments

• On July 07, 2023, the Apollo Proton Cancer Centre (APCC) partnered with Ion Beam Applications SA (IBA). The collaboration aims to train oncologists on proton beam therapy and facilitate the development of cancer care. Over 1,000 patients from 33 countries have been treated with proton beam therapy so far, said APCC. The therapy allows for non-invasive, targeted tumor treatment while minimizing damage to surrounding tissues.
• On October 20, 2021, IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, released the launch of the world’s first online platform dedicated to proton therapy systems.
• On May 7, 2020, Hitachi, Ltd. launched its advanced proton therapy system at Clínica Universidad de Navarra (Madrid, Spain), for the treatment of various types of cancers. Clínica Universidad de Navarra is the first hospital in which Hitachi has delivered the whole proton therapy system in Europe.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global proton therapy systems market. The pandemic created unprecedented challenges for pharmaceutical industries worldwide, including the global proton therapy systems market by temporarily disrupting many clinical trials and research activities due to the redirected focus on the COVID-19 pandemic and its related restrictions. The pandemic also disrupted the supply chain of these proton therapy systems globally.

Why Purchase the Report?

• To visualize the global proton therapy systems market segmentation based on type, set-up, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of proton therapy systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global proton therapy systems market report would provide approximately 69 tables, 70 figures, and 187 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies